Episode
2025 Year in Review - Part 1
- Podcast
- Eyewire News: The Podcast
- Published
- Dec 24, 2025
- Duration seconds
- 577
- Processing state
not_requested- Canonical source
- https://traffic.megaphone.fm/BMCL2456331568.mp3
Actions
POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/2025-year-in-review-part-1/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/2025-year-in-review-part-1.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
There were several advancements made during the first 6 months of 2025, including the first FDA approval for neurodegenerative disease MacTel; the approval of a first-of-its-kind drug for dry eye disease; advancements in premium IOLs; the approval of an excimer laser platform, and the launch of a new presbyopia drop. Learn more about your ad choices. Visit megaphone.fm/adchoices